morphine hydrochloride injection

DRUG3 trials

Sponsors

Luye Pharma Group Ltd., Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd

Conditions

Pain, PostoperativePostoperative Analgesia

Phase 2

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

CompletedNCT06204120

Luye Pharma Group Ltd.Pain, Postoperative

Start: 2022-11-25End: 2023-07-04Updated: 2024-01-12

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

RecruitingNCT06467409

Luye Pharma Group Ltd.Pain, Postoperative

Start: 2024-01-26End: 2025-01-31Target: 150Updated: 2024-06-21

Phase 3

Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia

CompletedNCT06949852

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. LtdPostoperative Analgesia

Start: 2024-08-07End: 2025-08-04Updated: 2026-06-25